Study notes increasing trends in non-operative management for small renal masses. Findings show significant variances in expectant management and focal ablation by year of diagnosis and race. From Dejan K Filipas et al.

Read here: oxford.ly/4bpfKEU

Recent findings suggest role for #HER2 in colorectal cancer: HER2+ CRC rates higher in left-sided RAS-WT patients. Findings highlight importance of HER2 testing in CRC management. #crcsm Kimmie Ng, MD, MPH Dana-Farber

Read more: oxford.ly/3wlWRnv

A study published in JNCI reports association between higher individual home prices with improved all-cause and cancer-specific mortality.

Read more: oxford.ly/4brvwz7
#Disparities #SDOH #cancer Alec Zhu Jonathan Evan Shoag 🇮🇱🇺🇸 Weill Cornell Medicine Urology University Hospitals Urology Institute

A trial finds RPLND the most cost-effective treatment for stage IIA seminoma - findings support clinical guideline consideration of including RPLND as a treatment option for well-selected patients. Dan Joyce

Read more: oxford.ly/3Qvyn24

Study reports #opioid use trends in older adults with cancer from 2012-2017. New opioid use was higher in cancer patients compared to those without cancer. #opioid s Yale School of Medicine Mayo Clinic

Read more: oxford.ly/3UMRTcS

Study by Howlader et al. reports that the COVID-19 pandemic led to significant decline in cancer incidence rates in the US, especially from March-May 2020, coinciding with stay-at-home orders. #COVID19 NCI Cancer Control

Read here: oxford.ly/44Arwdw

Commentary by Letícia Nogueira and Robin Yabroff discusses connections between #ClimateChange and cancer through an Environmental Justice perspective. American Cancer Society #SDOH

Read more here: oxford.ly/3JSdeLO

An editorial by Robin Yabroff et al. reaffirms the JNCI journals' commitment to diversity, equity and inclusion. #DEI

Read more here: oxford.ly/3QBdmCS

Excited to share our last publication at JNCI on how low physical function postcancer diagnosis is associated with higher mortality risk in postmenopausal women! Thanks to all co-authors! Christina Dieli-Conwright, PhD, MPH Alexi Vasbinder, PhD, RN academic.oup.com/jnci/advance-a…

The Predict tool, widely used for early-stage breast cancer prognosis, underestimates 5-year mortality for women with second ER+ breast cancer and in certain subgroups with second ER- breast cancer. @KalaVisvanathan

Read here: oxford.ly/3xZGFbO

Older, rural, and lower-income patients are less likely to be seen at CoC-accredited facilities for cancer care, suggesting access barriers. #healthequity Lindsay Sabik Pitt Health Policy and Management

Read more here: oxford.ly/3xSl8Sr

The Gabriella Miller Kids First Pediatric Research Program (Kids First) provides access to genetic and clinical data from patients with #pediatriccancer and birth defects to uncover their genetic etiology. NCI Cancer Control

Read more: oxford.ly/49SjNbx

The REASURE trial investigates whether diffusion-weighted #MRI can assess response in patients with metastatic #prostatecancer with bone lesions, where traditional imaging is ineffective. The Royal Marsden NHS Foundation Trust

Read here: oxford.ly/3UIIYcx

A retrospective study by Zaanan et al. suggests that adjuvant chemotherapy provides significant survival benefits for high-risk stage II and III small bowel adenocarcinoma. #crcsm Hôpital européen Georges-Pompidou AP-HP

Read more here: oxford.ly/44cQXBF

A new literature review underscores the need for rigorous methods to estimate real-world disease progression in lung cancer. #realworldevidence

Read more here: oxford.ly/3U93bqe

Out in JNCI! Rationale and design effectiveness-implementation trials for Systematic Symptom Management in the IMPACT Consortium. #PROs

Read more here: oxford.ly/3WkAtWh

A systematic review of 20 #RCTs of Antibody-Drug Conjugates by Suzuki et al. shows some increased adverse events like fatigue, nausea, and neuropathy, but no increase in febrile neutropenia. Toshiki Kuno, MD, PhD, FESC, FSCAI

Read more here: oxford.ly/3Ur71fA

Out in JNCI! Cascade testing using multigene panels for hereditary cancer can identify unexpected actionable findings in relatives of patients with cancer. #riskreduction #hereditarycancer Invitae

Read more here: oxford.ly/49LEPJ4

A study by Egemen et al. discusses an approach for developing effective #AI -based image recognition algorithms for medical screening and diagnostics, including cervical cancer screening. Didem Egemen Cancer Epi & Genetics

Read more: oxford.ly/4d5spP6

A study published in the Journal of the National Cancer Institute (JNCI) examined processes for identifying #caregivers and screening for distress management in community oncology. #cancersupport

Read it here: oxford.ly/3U44s1U